Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

计划入组 1,500 人 · 首次发布于 2014 年 3 月 31 日

COMparison of Physiological Algorithms for Real-time Evaluation of Atrial Fibrillation

计划入组 1,000 人 · 首次发布于 2016 年 12 月 20 日

WHOOP Abnormal Rhythm Notification

计划入组 653 人 · 首次发布于 2023 年 4 月 12 日

HuCo Heart

heart regeneration therapy (congestive heart failure)

TBM-TRANSPLANT (Heart)

HEART RHYTHM CLINICAL AND RESEARCH SOLUTIONS, LLC

United States

Catheter Precision

United States

Rhythm Pharmaceuticals

United States

BioXcel Therapeutics to Submit sNDA for At-Home Use of IGALMI in Agitation Treatment

Milestone Pharmaceuticals to Present Etripamil PSVT Data at AHA Scientific Sessions 2025

Brisk Walking Significantly Reduces Risk of Heart Rhythm Disorders, New Study Finds